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Background: Acute coronary lesions are known to be the most common
trigger of out of hospital cardiac arrest (OHCA). But the diagnosis of acute
coronary artery disease in survivors of out-of-hospital cardiac arrest is diffi-
cult. The aim of the present study was to assess the predictive value clinical
and electrpcardiographic features in diagnosing the presence of acute coronary
lesions among out-of-hospital cardiac arrest patients.
Methods: Clinical and electrocardiographic data collected before coronary
angiography were analyzed to determine whether they could be used to predict
the presence of recent coronary – artery occlusion on angiography.
Results: 54 patients underwent coronarography angiography after OHCA;
42% of patients had ST-segment elevation and 57% of patients had other ECG
patterns on post-restoration of spontaneous circulation (ROSC) ECG. Acute
coronary lesions was found in 66% of patients; Significant coronary artery
disease was observed in 83% of patients with ST-segment elevation and in
55% of patients with other ECG patterns on post-ROSC ECG (p = 0.03).
Significant coronary artery disease was observed in 100% of patients with
chest pain before the arrest and in 55% of patients without chest pain
(p=0.02). Chest pain has a good positive predictive value but a low negative
predictive value in diagnosing the presence of acute or presumed recent coro-
nary artery lesions (100% and 45%, respectively).
Conclusion: ST-segment elevation and chest pain before arrest after
OHCA should not be considered as strict selection criteria for performing
emergent coronary angiography in patients resuscitated from OHCA; even in
the absence of ST-segment elevation on post- return of spontaneous circula-
tion ECG, acute culprit coronary lesions may be present and considered the
trigger of cardiac arrest.
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Introduction and Objectives: The Global Registry of Acute Coronary
Events (GRACE) risk score provides an estimate of the probability of death
within 6 months of hospital discharge in patients with acute coronary
syndrome (ACS). Our aim was to assess the validity of this risk score in a
contemporary cohort of patients admitted to an Algerian hospital.
Methods: The study involved 383 consecutive patients with ACS
evaluated between January 2010 and January 2014. Their vital status was
determined 6 months after hospital discharge and the validity of the GRACE
risk score was evaluated by assessing its calibration and its discriminatory
capacity.
Results: In total, 142 (37%) patients were admitted for ST-elevation myo-
cardial infarction (STEMI) and 241 (67%) for non-ST-elevation myocardial
infarction (NSTEMI). Percutaneous revascularization was performed in 249
(65%). The median GRACE risk score was 121 [interquartile range, 96-144].
Mortality 6 months after discharge was 4.9%. The calibration of the GRACE
risk score was acceptable and its discriminatory capacity was excellent.
Conclusions: The GRACE risk score for predicting death within 6 months
of hospital discharge was validated and can be used in patients with ACS. It
would be wise to include the GRACE risk score in the medical records of
these patients.
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Early primary prevention of atherosclerosis in high-risk patients is still a
major challenge to decrease the burden of cardiovascular diseases. Treatment
by statins is part of the strategies for prevention either by lowering LDL-CT
or by their pleiotropic effects. Indeed, statins improve endothelial function,
enhance the stability of atherosclerotic plaques, decrease inflammation and
reactive oxygen species (ROS) production (at least at myocardium level).
Our aim was to determine the long-term effect of atorvastatin on mitochon-
drial function of myocardium focusing on ROS susceptibility. The Watanabe
rabbit was used in this study as a hereditary hypercholesterolemia animal
model.
Thirty-three Watanabe rabbits were randomly assigned to two groups: a
control group without treatment and a group treated with atorvastatin (per os
2.5 mg. kg-1.day-1) from the age of 3 months. Blood was sampled monthly
from the median artery of the ear for lipid analysis. The myocardium was
sampled at the age of 3, 6, 9 and 12 months in both groups. Cardiac fibers
were then permeabilized (using saponin). Maximal mitochondrial oxygen
consumption was measured in vitro after incubating or not fibers with ROS
(Fenton reaction) in order to assess the susceptibility of the mitochondrial
function to ROS.
Decrease in blood lipids showed the efficiency of the atorvastatin treat-
ment. After exposure to ROS, decrease in maximal mitochondrial oxygen
consumption was significantly less important in treated than in control group
from the age of 9 months (respectively 24.8±1.5% vs 40.9±2.8%, p=0.0006).
No difference was observed in younger rabbits.
Our results show that long term atorvastatin treatment decreases mitochon-
drial vulnerability to ROS (6 months) in Watanabe heritable hyperlipidemic
rabbits. This effect may be related to an increase in antioxydant capacities
(measurements in progress) and/or decrease in ROS production (by mitochon-
dria or NADPH oxidase) and/or lower potential ROS target.
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